Gene · 7049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In Vitro Assessment of the Role of p53 on Chemotherapy Treatments in Neuroblastoma Cell Lines. | Pharmaceuticals (Basel) | 2021 | 34832966 | PubTator, text mining | PubMed |
| Mechanisms, Diagnosis and Treatment of Bone Metastases. | Cells | 2021 | 34831167 | PubTator, text mining | PubMed |
| Transcriptional and Metabolic Investigation in 5'-Nucleotidase Deficient Cancer Cell Lines. | Cells | 2021 | 34831141 | PubTator, text mining | PubMed |
| Sleep Disruption Worsens Seizures: Neuroinflammation as a Potential Mechanistic Link. | Int J Mol Sci | 2021 | 34830412 | PubTator, text mining | PubMed |
| Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis. | Mol Ther Nucleic Acids | 2021 | 34786209 | PubTator, text mining | PubMed |
| Sulfatase-2 Regulates Liver Fibrosis through the TGF-β Signaling Pathway. | Cancers (Basel) | 2021 | 34771445 | PubTator, text mining | PubMed |
| Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway. | PLoS One | 2021 | 34767591 | PubTator, text mining | PubMed |
| The multifaceted involvement of exosomes in tumor progression: Induction and inhibition. | MedComm (2020) | 2021 | 34766148 | PubTator, text mining | PubMed |
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Expression of TGF-β Signaling Regulators and Prognosis in Human Esophageal Cancer. | Comput Math Methods Med | 2021 | 34725559 | PubTator, text mining | PubMed |
| A Humanized Mouse Strain That Develops Spontaneously Immune-Mediated Diabetes. | Front Immunol | 2021 | 34721418 | PubTator, text mining | PubMed |
| Identification and functional analysis of a three-miRNA ceRNA network in hypertrophic scars. | J Transl Med | 2021 | 34715879 | PubTator, text mining | PubMed |
| Parallels between the Developing Vascular and Neural Systems: Signaling Pathways and Future Perspectives for Regenerative Medicine. | Adv Sci (Weinh) | 2021 | 34693660 | PubTator, text mining | PubMed |
| CircPTK2 (hsa_circ_0003221) Contributes to Laryngeal Squamous Cell Carcinoma by the miR-1278/YAP1 Axis. | J Oncol | 2021 | 34691176 | PubTator, text mining | PubMed |
| Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions. | J Exp Clin Cancer Res | 2021 | 34686187 | PubTator, text mining | PubMed |
| Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study. | Cells | 2021 | 34685674 | PubTator, text mining | PubMed |
| Metabolic Stress Adaptations Underlie Mammary Gland Morphogenesis and Breast Cancer Progression. | Cells | 2021 | 34685621 | PubTator, text mining | PubMed |
| RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer. | Pharmaceutics | 2021 | 34683988 | PubTator, text mining | PubMed |
| Periostin Exon-21 Antibody Neutralization of Triple-Negative Breast Cancer Cell-Derived Periostin Regulates Tumor-Associated Macrophage Polarization and Angiogenesis. | Cancers (Basel) | 2021 | 34680221 | PubTator, text mining | PubMed |
| Epigenetic interplay between methylation and miRNA in bladder cancer: focus on isoform expression. | BMC Genomics | 2021 | 34674656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7049/papers?page=38